Novel approaches to tuberculosis vaccine development | Zendy

Stefan H. E. Kaufmann | Zendy; January Weiner | Zendy; C. Fordham von Reyn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel approaches to tuberculosis vaccine development

Author(s) -

Stefan H. E. Kaufmann,

January Weiner,

C. Fordham von Reyn

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.10.018

Subject(s) - tuberculosis , medicine , tuberculosis vaccines , virology , bcg vaccine , mycobacterium tuberculosis , infectious disease (medical specialty) , immunology , disease , vaccination , pathology

Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette-Guérin (BCG) vaccine offers only limited protection against TB. New vaccine candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as live mycobacterial vaccines. Current developments in TB vaccines are summarized in this review.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research